Our portfolio of pharma-sponsored trials provides local access to promising investigational therapies.

Expanded treatment selection across therapy classes

Combined DNA and quantitative RNA profiling from limited tumor tissue provides the opportunity for treatment with a broader range of therapeutic modalities.

Strata Select™ is a pan-solid tumor molecular profiling test for patients with advanced cancer that provides treatment selection guidance for immunotherapy and beyond.

Longitudinal disease monitoring across all disease stages

Ultra-sensitive ctDNA-based recurrence and treatment response monitoring informs treatment decisions throughout the patient care journey.

One tissue sample powers comprehensive treatment selection and personalized liquid-biopsy based monitoring through Strata Sentinel.

Local access to more precision treatments

Strata PATH™ is a multi-arm platform trial testing novel treatment hypotheses for existing FDA-approved therapies across multiple tumor types.

A range of therapeutic classes will be evaluated in Strata PATH™ including targeted therapies, antibody-drug conjugates, immunotherapies and angiogenesis inhibitors.

Customized service and support

Strata Oncology provides the infrastructure and expertise to deliver precision cancer care to large populations.

• Dedicated customer success team
• Clinical education and consults
• Customized workflows
• Research support and partnership

• ChristianaCare
• Kaiser Permanente
• Lehigh Valley Health Network
• Ochsner
• University of Wisconsin Carbone Cancer Center

Help your patients gain access to cutting-edge treatment options.

You don’t have to be a Principal Investigator or Sub-Investigator to participate in research! TrialSpark partners with physicians to help their patients access new treatments by connecting them with nearby clinical trials.

Benefits of partnering with TrialSpark

• Provide innovative, new, treatments to patients who would not otherwise have access to these options
• Contribute to the research and development of new treatment options for patients in a lightweight capacity
• Receive compensation for time spent identifying and speaking with patients regardless of whether patients enroll into a study
• Receive TrialSpark’s support to identify patients and refer them to studies
• Increase patient and physician diversity in clinical research through community participation, broadening patient reach and retention through referrals from physicians they know and trust

Access to more studies

Sites in TrialSpark’s network gain first access to new studies. We work with you to understand your site’s study experience and interests, bring relevant study opportunities directly to you, and handle sponsor interactions on your behalf.

Faster feasibility & selection

Based on the data you have provided on your site’s study experience and interests, we present you with relevant study opportunities and move your site through our feasibility process. Once presented with a study opportunity, TrialSpark works fast to qualify your site and move toward site activation - typically within 1-2 weeks.

Access to site technology and enrollment support

Reduce unnecessary work using TrialSpark resources designed specifically for sites. Our proprietary software enables sites to bypass manual EDC entry, and our in-house research nurses provide screening support to help you enroll as quickly as possible.

Best-in-class monitoring partners

Our monitors are the best in the business. They are responsive, knowledgeable, and won't waste your time.

Not specified